It is investigated the therapeutic efficacy of combined action of ultrasound and porous silicon nanoparticles loaded with anticancer drug doxorubicin by using an 
Introduction
Sonodynamic therapy (SDT), which is one of the modern approaches to the treatment of malignant tumors, is based on an application of ultrasound irradiation (USI) with relatively low intensity, whose action is locally enhanced by using special substances, i.e. sonosensitizers [1] . When nanoparticles (NPs) are used as sonosensitizers, the therapeutic efficacy of USI occurs due to heating effect (hyperthermia), acoustic cavitation and sonochemical reactions of generation of active radicals nearby NPs [1, 2] .
Among various biomedical nanomaterials silicon nanoparticles (SiNPs) are low toxic and biodegradable [3, 4] . Developed internal surface of porous SiNPs is favorable for How to cite this article: Zinovyev S. V., Saprikina N.S., Kargina J. V., Le-Deygen I. M., Sviridov A. P., Bazylenko T. Yu., Fesenko I. K., and Timoshenko V.Yu., (2018), "In- 
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PhysBioSymp17 a substantial reduction of the threshold of acoustic cavitation that is promising for SDT [5] . Nanometer size particles can accumulate in tumor tissues in a natural way, penetrating through the pores in the blood vessels of malignant tumors, the size of which ranges from 100 to 300 nm. To deliver drug-loaded SiNPs into the cells the former can be exposed to USI with pressure amplitude exceeding the threshold of inertial cavitation. Additionally, drug-loaded SiNPs covered with thermally sensitive polymer can be used for controlled drug release under external heating [6] , which can be also induced by therapeutic USI [7] . Our work is aimed to in-vivo studies of porous SiNPs as sonosensitizers for SDT and nanocontainers for anticancer drug, whose release can be triggered by therapeutic USI.
Materials and methods
The study of biological tolerance and biological efficiency of SiNPs were performed in mice with well-developed transplantable LLC tumors in the later stages of their growth. We use nanoparticles of mesoporous silicon (MPSi) prepared by standard electrochemical method [3] [4] [5] and non-porous nanocrystalline SiNPs (NCSi) formed by plasma-assisted fragmentation of polycrystalline Si powder [8] . In order to control the temperature dynamics of the tumor growth during USI the following approaches were used: (i) functional microwave thermometry before and after performing the ultrasonic action; (ii) contact temperature sensor of the digital medical precision thermometer directly during USI.
The control group of mice did not receive nanoparticles and no USI was performed.
The results were statistically processed using Student's t-test with a reliability of 0.95.
Results and discussion
In the case intratumorally injected MPSi NPs the biological effect of therapeutic importance was evaluated by analyzing the life expectancy increase and by the criterion of inhibition of growth of tumors. The average life expectancy of laboratory animals of the experimental group was 18% more than in the group of intact control (mice with inoculated tumor LLC is not subjected to any exposure) as it is shown in Fig.1 . A study of the kinetics of tumor growth showed that in mice of the experimental group, the primary site of the tumor grew slowly than in the control group throughout the observation period. The difference in the percentage of inhibition of growth of tumors reached 31% to 27 day from the beginning of the development of tumors (see Fig.2 ).
Our experiments performed with nanoparticles of non-porous structure (NCSi) showed that the average duration of mice lifetime of the experimental group was 16% more than in the control group, and the difference in the percentage of inhibition of the tumor was about 26%. It was found that intravenously administered NCSi nanoparticles did not induce any immediate or remote toxic effects of therapeutic significance.
In order to evaluate an effect of USI the following groups of animals were investigated:
1. Mice subjected to the action of ultrasonic radiation with the previously entered intratumorally MPSi NPs.
2. Mice subjected to the action of ultrasonic radiation with the previously entered intratumorally MPSi NPS loaded with doxorubicin. control group (Fig. 6) . Thus, in contrast to the control group, the death of animals begins only in the later stages of cancer development. Animals of the third group (intratumoral introduction porous silicon nanoparticles loaded with doxorubicin without conducting ultrasonic treatment) observed growth inhibition of tumors by 49% and increase life expectancy by 24%. 
Conclusions
The obtained results have revealed the biological tolerability of porous and non-porous silicon nanoparticles under interstitial or intravenous administrations. The most pronounced therapeutic effect was achieved when conducting sonodynamic therapy with the specified parameters in the case of porous silicon nanoparticles load with doxorubicin that demonstrates new opportunities for the use of biocompatible silicon nanoparticles in sonodynamic therapy of malignant tumors.
